Anzeige
Mehr »
Login
Dienstag, 21.01.2025 Börsentäglich über 12.000 News von 682 internationalen Medien
Aktienchance des Jahres! Ihre Chance auf explosive Gewinne!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
302 Leser
Artikel bewerten:
(1)

Evercare Group launches Evercare Foundation to help bridge the gap in inequality in healthcare

Finanznachrichten News

- The Foundation will provide long-term solutions to improve healthcare access in Africa and South Asia, while contributing to the 2030 Sustainable Development Goals.

ISLAMABAD, Pakistan, March 15, 2022 /PRNewswire/ -- The Evercare Group today announced the launch of the Evercare Foundation, a non-profit organization working towards equitable health for all and the development of more resilient health systems across the low- and middle-income countries in Africa and South Africa.

The Foundation will serve as the philanthropic arm of the Evercare Group and will build on the footprint of Evercare Group of 29 hospitals, 13 clinics, 88 diagnostic centres and have access to 11,400 caregivers, serving over 3.3 million people in Bangladesh, India, Pakistan, Nigeria, and Kenya.

Speaking at the 18th Dubai International Humanitarian Aid & Development Conference & Exhibition (DIHAD), Massimiliano Colella, CEO of Evercare said: "The Foundation presents another key avenue through which we can continue to deliver meaningful change and positive impact to traditionally underserved communities. Through focused partnerships and deliberate investments, the Evercare Foundation will continue to build sustainable development across our areas of operation."

Low and middle-income countries continue to suffer from insufficient investment in healthcare, leading to often highly strained and burdened systems that are unable to keep up with demands of patients, especially in these times of the pandemic. According to the World Bank, if current trends continue, up to 5 billion people will be unable to access health care by 2030 with 56% of the population lacking sufficient health-care coverage in rural areas globally.

Joumana Atwani, Director of Partnerships and External Affairs of the Evercare Group and Lead of Evercare Foundation said: "The Foundation is driven by an ambition to create long-term positive social change for vulnerable communities who have a fundamental right to good health and wellbeing. Through the Evercare Foundation, we aim to focus on communities who have limited or no access to quality healthcare.'

To realize our vision of 'a world with equitable health for all,' the Foundation will primarily focus on women and children - with priority being on women and girls' adolescent health and wellbeing, including ante and post-natal care, screening for non-communicable diseases such as breast and cervical cancer. In children's health the Foundation will focus on treatment and rehabilitation for congenital birth defects and trauma related conditions and children related disease prevention and immunization.

One example is of 5-year-old Abdul Rehman from Pakistan, who was born with congenital deafness and whose family could not afford the treatment. Surgeons at Evercare Hospital Lahore successfully inserted a cochlear implant free of cost and now Abdul can hear for the time and able to attend school.

The Foundation will equally invest in initiatives related to human resources in health and leveraging the Evercare Group's integrated healthcare corridor to strengthen health systems by supporting clinical trials and complex healthcare cases across borders.

About the Evercare Foundation

The Evercare Foundation is an independent philanthropic organization established to support the impact driven initiatives of the Evercare Group. The Foundation provides vulnerable communities with equitable access to quality healthcare and create long term positive social change.

The priority areas of the Foundation are vulnerable communities in low and middle-income countries, with a primary focus on women and children who are marginalized by health and socio-economic inequities.

About the Evercare Group

The Evercare Group believes access to healthcare is a fundamental right and invests in emerging markets to bring private, quality-driven healthcare to meet the needs of local people.

Evercare has responded to a global challenge to ensure well-being at all ages is provided to those living in emerging markets as a pillar to support sustainable economic development. With this, the Group is leading the way in transforming the traditional healthcare model through its integrated cross-continents platform, its impact-driven model, and quality-driven hospitals.

The Evercare Group operates as an integrated healthcare delivery platform in emerging markets across Africa and South Asia, including India, Pakistan, Bangladesh, Kenya, and Nigeria.

Evercare is wholly owned by the Evercare Health Fund, a US $1bn emerging markets healthcare fund managed by TPG and backed by its global impact investing platform TPG Rise. The Evercare Health Fund is comprised of the world's leading impact investors and global development finance institutions.

© 2022 PR Newswire
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.